Comorbidities in patients with psoriasis: The role of the dermatologist - 14/12/17
Doi : 10.1016/j.jaad.2017.01.057
Mohammed D. Saleem, MD, MPH ⁎ 
, Steven R. Feldman, MD, PhD
, Steven R. Feldman, MD, PhD Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina
∗Correspondence to: Mohammed D. Saleem, MD, MPH, Department of Dermatology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071.Department of DermatologyWake Forest School of MedicineMedical Center BoulevardWinston-SalemNC27157-1071
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories, L.P. Dr Feldman is a speaker for Janssen and Taro. He has received research, speaking, or consulting support from Galderma, GSK/Stiefel, Almirall, Leo Pharma, Baxter, Boeringer Ingelheim, Mylan, Celgene, Pfizer, Valeant, Abbvie, Cosmederm, Anacor, Astellas, Janssen, Lilly, Merck, Merz, Novartis, Qurient, National Biological Corporation, Caremark, Advance Medical, Suncare Research, Informa, UpToDate, and the National Psoriasis Foundation. He is the founder and majority owner of www.DrScore.com and the founder and part owner of Causa Research, a company dedicated to enhancing patients' adherence to treatment. Dr Saleem has no conflicts of interest to declare. |
|
| Reprints not available from the authors. |
© 2017
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 77 - N° 1
P. 191-192 - juillet 2017 Retour au numéro
Article précédent
- The role of cannabinoids in dermatology
- Jessica S. Mounessa, Julia A. Siegel, Cory A. Dunnick, Robert P. Dellavalle
- Beyond JAAD July 2017: Articles of interest to dermatologists from the nondermatologic literature
- Andrew Bronin, Robert Phelps, Robert Sidbury
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?